PRCC Antikörper (C-Term) (HRP)
Kurzübersicht für PRCC Antikörper (C-Term) (HRP) (ABIN8019423)
Target
Alle PRCC Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- Anti-PRCC Antibody HRP Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- A synthetic peptide corresponding to a sequence at the C-terminus of human PRCC.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
Haltbarkeit
- 12 months
-
-
- PRCC (Papillary Renal Cell Carcinoma (Translocation-Associated) (PRCC))
-
Andere Bezeichnung
- PRCC
-
Hintergrund
-
Background: This gene encodes a protein that may play a role in pre-mRNA splicing. Chromosomal translocations (X,1)(p11,q21) that result in fusion of this gene to TFE3 (GeneID 7030) have been associated with papillary renal cell carcinoma. A PRCC-TFE3 fusion protein is expressed in affected carcinomas and is likely associated with altered gene transactivation. This fusion protein has also been associated with disruption of the cell cycle.
Gene Full Name: proline rich mitotic checkpoint control factor
-
Gen-ID
- 5546
-
UniProt
- Q92733
Target
-